Cosimo De Nunzio

Pubblicazioni

Titolo Pubblicato in Anno
Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer. An Italian multicenter real life study BMC CANCER 2017
The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome. a comprehensive analysis of all published clinical trials BMC UROLOGY 2017
Presence and severity of lower urinary tract symptoms are inversely correlated with the risk of prostate cancer on prostate biopsy MINERVA UROLOGICA E NEFROLOGICA 2017
Can Long-term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? CURRENT UROLOGY REPORTS 2017
Is early benign prostatic hyperplasia (BPH) treatment worthwhile? UROLOGIA 2017
Quality of life after prostate cancer diagnosis: data from the pros-IT CNR EUROPEAN UROLOGY FOCUS 2017
Physical activity as a risk factor for prostate cancer diagnosis. a prospective biopsy cohort analysis BJU INTERNATIONAL 2016
Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer. a single biopsy cohort analysis PROSTATE CANCER AND PROSTATIC DISEASES 2016
541 Metabolic abnormalities linked to an increased cardiovascular risk are associated with higher storage lower urinary tract symptoms EUROPEAN UROLOGY. SUPPLEMENTS 2016
Trends in the use of partial nephrectomy for cT1 renal tumors. analysis of a 10-yr european multicenter dataset EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2016
A novel stepwise micro-TESE approach in non obstructive azoospermia BMC UROLOGY 2016
Detrusor overactivity increases bladder wall thickness in male patients: a urodynamic multicenter cohort study NEUROUROLOGY AND URODYNAMICS 2016
Inflammatory mediators in the development and progression of benign prostatic hyperplasia NATURE REVIEWS. UROLOGY 2016
The impact of central obesity on storage luts and urinary incontinence after prostatic surgery CURRENT UROLOGY REPORTS 2016
Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasia DRUGS OF TODAY 2016
Tamsulosin or silodosin adjuvant treatment is ineffective in improving shockwave lithotripsy outcome. A short-term follow-up randomized, placebo-controlled study JOURNAL OF ENDOUROLOGY 2016
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter Corona database EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2016
Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk. Results from a multicenter biopsy study BMC CANCER 2016
Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy. Results from a multicentre prospective study BMC CANCER 2016
MP35-11 METABOLIC ABNORMALITIES LINKED TO AN INCREASED CARDIOVASCULAR RISK ARE ASSOCIATED WITH HIGHER STORAGE LOWER URINARY TRACT SYMPTOMS THE JOURNAL OF UROLOGY 2016

ERC

  • LS4_9
  • LS4_12
  • LS7
  • LS7_1
  • LS7_6

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Urology, prostate cancer, benign prostatic hyperplasia, Urodynamic, uro-oncology, minimally invasive treatment, laparoscopic and robotic

Keywords

urology
benign prostate hyperplasia
Castration-resistant prostate cancer
urodynamic testing
kidney calculi
kidney cancer
#bladder cancer
metabolic disorders
Risk factor for prostate cancer
Minimally invasive endoscopic surgery

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma